Company GuiZhou SanLi Pharmaceutical Co.,Ltd

Equities

603439

CNE1000040B4

Pharmaceuticals

End-of-day quote Shanghai S.E. 23:00:00 13/05/2024 BST 5-day change 1st Jan Change
16.53 CNY +1.41% Intraday chart for GuiZhou SanLi Pharmaceutical Co.,Ltd +3.64% -12.45%

Business Summary

Guizhou Sanli Pharmaceutical Co Ltd is a company mainly engaged in the research and development, production and sales of Chinese patent medicines. The Company's product lines cover various areas, including pediatrics, respiratory systems, cardio-cerebrovascular and gastroenterology. Its main products are Kaihoujian spray (Pediatric Use), Kaihoujian spray and Qiangli Gastrodia Elata Eucommia capsules. The Kaihoujian spray (Pediatric Use) and Kaihoujian spray are used for the treatment of respiratory and oral diseases, and the Qiangli Gastrodia Elata Eucommia capsule is used for the treatment of cardiovascular and cerebrovascular diseases. The Company mainly sells its products through specialized academic marketing.

Number of employees: 1,557

Sales per Business

CNY in Million2022Weight2023Weight Delta
Respiratory System Medications
79.5 %
- - 1,300 79.5 % -
Blood Medications
6.9 %
- - 112 6.9 % -
Gynecological Medications
4.7 %
43 3.6 % 77 4.7 % +79.81%
Tonic Medicine
2.8 %
- - 46 2.8 % -
Cardiovascular and Cerebrovascular Drugs
2.5 %
- - 41 2.5 % -
Orthopedic Medication
2.2 %
- - 35 2.2 % -
Other
1.3 %
53 4.4 % 22 1.3 % -59.40%
Other Business
0.0 %
0 0.0 % 1 0.0 % +53.42%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,201 100.0 % 1,635 100.0 % +36.10%

Managers

Managers TitleAgeSince
Chief Executive Officer 39 31/12/07
Director of Finance/CFO 61 31/08/13
Director/Board Member 39 30/09/14
Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 61 11/12/22
Director/Board Member 54 11/12/22
Chief Executive Officer 39 31/12/07
Director of Finance/CFO 61 31/08/13
Director/Board Member 39 30/09/14
Director/Board Member 50 31/08/11
Chairman 39 28/02/11
Director/Board Member 31 31/12/15
Director/Board Member 50 11/12/22
Director/Board Member 41 22/11/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 411,386,216 166,053,510 ( 40.36 %) 1,524,000 ( 0.3705 %) 40.36 %

Shareholders

NameEquities%Valuation
Hai Zhang
46.20 %
188,668,440 46.20 % 408 M ¥
23,347,947 5.718 % 50 M ¥
21,924,559 5.369 % 47 M ¥
Shanghai Guosheng Capital Management Co., Ltd.
5.020 %
20,500,000 5.020 % 44 M ¥
Shu Yu Yang
1.094 %
4,465,700 1.094 % 10 M ¥
AXA-SPDB Investment Managers Co., Ltd.
0.9897 %
4,041,300 0.9897 % 9 M ¥
Zhong Ou Asset Management Co., Ltd
0.8930 %
3,646,469 0.8930 % 8 M ¥
Tianjin Zhonghe Yida Investment LLC
0.4627 %
1,889,400 0.4627 % 4 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
0.4218 %
1,722,200 0.4218 % 4 M ¥
China Asset Management Co., Ltd.
0.3989 %
1,629,000 0.3989 % 4 M ¥

Company contact information

GuiZhou SanLi Pharmaceutical Co., Ltd.

Xiayun Industrial Park Pingba District

561100, Anshun

+

http://www.gz-sanli.com
address GuiZhou SanLi Pharmaceutical Co.,Ltd(603439)

Sales per Business

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
16.53 CNY
Average target price
19.84 CNY
Spread / Average Target
+20.02%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603439 Stock
  4. Company GuiZhou SanLi Pharmaceutical Co.,Ltd